Actively Recruiting

Phase Not Applicable
Age: 30Years - 80Years
All Genders
NCT05773885

Telerehabilitation in People With Parkinson's Disease

Led by IRCCS San Raffaele Roma · Updated on 2025-03-30

40

Participants Needed

2

Research Sites

186 weeks

Total Duration

On this page

Sponsors

I

IRCCS San Raffaele Roma

Lead Sponsor

M

Ministry of Health, Italy

Collaborating Sponsor

AI-Summary

What this Trial Is About

Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed. The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.

CONDITIONS

Official Title

Telerehabilitation in People With Parkinson's Disease

Who Can Participate

Age: 30Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 30 and 80 years
  • Diagnosis of Parkinson's Disease according to Movement Disorders Society criteria
  • Hoehn & Yahr score between 2 and 3 (ON-state)
  • No significant dyskinesias (MDS-UPDRS items 4.1 and 4.2 score  2)
  • No cognitive impairment (MoCA score  18)
  • Stabilized medication treatment
  • Access to the Internet for telerehabilitation
  • Caregiver available during telerehabilitation sessions
  • Sufficient cognitive and language abilities to understand and follow study procedures
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Cognitive problems or low compliance preventing use of telerehabilitation system
  • Other neurological diseases, psychiatric issues, or personality disorders
  • Musculoskeletal diseases impairing movement
  • Significant dyskinesias (MDS-UPDRS items 4.1 and 4.2 score > 2)
  • Cognitive impairment (MoCA score < 18)
  • Severe cognitive or language deficits preventing understanding or compliance
  • Blurred or low vision problems
  • Hearing or speech impairments affecting participation
  • No signed informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

San Raffaele Cassino

Cassino, Frosinone, Italy, 03043

Not Yet Recruiting

2

IRCCS San Raffaele Roma

Rome, Italy, Italy, 00163

Actively Recruiting

Loading map...

Research Team

D

Dr. Sanaz Pournajaf, DPT

CONTACT

D

Dr. Raimondo Torcisi, PT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here